Cargando…

Determinants of subject visit participation in a prospective cohort study of HTLV infection

BACKGROUND: Understanding participation in a prospective study is crucial to maintaining and improving retention rates. In 1990–92, following attempted blood donation at five blood centers, we enrolled 155 HTLV-I, 387 HTLV-II and 799 HTLV seronegative persons in a long-term prospective cohort. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: DeVita, Deborah A, White, Mary C, Zhao, Xin, Kaidarova, Zhanna, Murphy, Edward L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660365/
https://www.ncbi.nlm.nih.gov/pubmed/19284565
http://dx.doi.org/10.1186/1471-2288-9-19
_version_ 1782165723513094144
author DeVita, Deborah A
White, Mary C
Zhao, Xin
Kaidarova, Zhanna
Murphy, Edward L
author_facet DeVita, Deborah A
White, Mary C
Zhao, Xin
Kaidarova, Zhanna
Murphy, Edward L
author_sort DeVita, Deborah A
collection PubMed
description BACKGROUND: Understanding participation in a prospective study is crucial to maintaining and improving retention rates. In 1990–92, following attempted blood donation at five blood centers, we enrolled 155 HTLV-I, 387 HTLV-II and 799 HTLV seronegative persons in a long-term prospective cohort. METHODS: Health questionnaires and physical exams were administered at enrollment and 2-year intervals through 2004. To examine factors influencing attendance at study visits of the cohort participants we calculated odds ratios (ORs) with generalized estimated equations (GEE) to analyze fixed and time-varying predictors of study visit participation. RESULTS: There were significant independent associations between better visit attendance and female gender (OR = 1.31), graduate education (OR = 1.86) and income > $75,000 (OR = 2.68). Participants at two centers (OR = 0.47, 0.67) and of Black race/ethnicity (OR = 0.61) were less likely to continue. Higher subject reimbursement for interview was associated with better visit attendance (OR = 1.84 for $25 vs. $10). None of the health related variables (HTLV status, perceived health status and referral to specialty diagnostic exam for potential adverse health outcomes) significantly affected participation after controlling for demographic variables. CONCLUSION: Increasing and maintaining participation by minority and lower socioeconomic status participants is an ongoing challenge in the study of chronic disease outcomes. Future studies should include methods to evaluate attrition and retention, in addition to primary study outcomes, including qualitative analysis of reasons for participation or withdrawal.
format Text
id pubmed-2660365
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26603652009-03-25 Determinants of subject visit participation in a prospective cohort study of HTLV infection DeVita, Deborah A White, Mary C Zhao, Xin Kaidarova, Zhanna Murphy, Edward L BMC Med Res Methodol Research Article BACKGROUND: Understanding participation in a prospective study is crucial to maintaining and improving retention rates. In 1990–92, following attempted blood donation at five blood centers, we enrolled 155 HTLV-I, 387 HTLV-II and 799 HTLV seronegative persons in a long-term prospective cohort. METHODS: Health questionnaires and physical exams were administered at enrollment and 2-year intervals through 2004. To examine factors influencing attendance at study visits of the cohort participants we calculated odds ratios (ORs) with generalized estimated equations (GEE) to analyze fixed and time-varying predictors of study visit participation. RESULTS: There were significant independent associations between better visit attendance and female gender (OR = 1.31), graduate education (OR = 1.86) and income > $75,000 (OR = 2.68). Participants at two centers (OR = 0.47, 0.67) and of Black race/ethnicity (OR = 0.61) were less likely to continue. Higher subject reimbursement for interview was associated with better visit attendance (OR = 1.84 for $25 vs. $10). None of the health related variables (HTLV status, perceived health status and referral to specialty diagnostic exam for potential adverse health outcomes) significantly affected participation after controlling for demographic variables. CONCLUSION: Increasing and maintaining participation by minority and lower socioeconomic status participants is an ongoing challenge in the study of chronic disease outcomes. Future studies should include methods to evaluate attrition and retention, in addition to primary study outcomes, including qualitative analysis of reasons for participation or withdrawal. BioMed Central 2009-03-10 /pmc/articles/PMC2660365/ /pubmed/19284565 http://dx.doi.org/10.1186/1471-2288-9-19 Text en Copyright ©2009 DeVita et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
DeVita, Deborah A
White, Mary C
Zhao, Xin
Kaidarova, Zhanna
Murphy, Edward L
Determinants of subject visit participation in a prospective cohort study of HTLV infection
title Determinants of subject visit participation in a prospective cohort study of HTLV infection
title_full Determinants of subject visit participation in a prospective cohort study of HTLV infection
title_fullStr Determinants of subject visit participation in a prospective cohort study of HTLV infection
title_full_unstemmed Determinants of subject visit participation in a prospective cohort study of HTLV infection
title_short Determinants of subject visit participation in a prospective cohort study of HTLV infection
title_sort determinants of subject visit participation in a prospective cohort study of htlv infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660365/
https://www.ncbi.nlm.nih.gov/pubmed/19284565
http://dx.doi.org/10.1186/1471-2288-9-19
work_keys_str_mv AT devitadeboraha determinantsofsubjectvisitparticipationinaprospectivecohortstudyofhtlvinfection
AT whitemaryc determinantsofsubjectvisitparticipationinaprospectivecohortstudyofhtlvinfection
AT zhaoxin determinantsofsubjectvisitparticipationinaprospectivecohortstudyofhtlvinfection
AT kaidarovazhanna determinantsofsubjectvisitparticipationinaprospectivecohortstudyofhtlvinfection
AT murphyedwardl determinantsofsubjectvisitparticipationinaprospectivecohortstudyofhtlvinfection